How does ozempic influence ghrelin the hunger hormone?

How Does Ozempic Influence Ghrelin, the Hunger Hormone?

Ozempic, also known as semaglutide, is a medication primarily used to treat type 2 diabetes. However, it has gained attention for its potential weight-loss benefits and effects on appetite regulation.

What is Ghrelin?

Ghrelin is a peptide hormone produced in the gastrointestinal tract that plays a crucial role in regulating appetite and food intake. It is often referred to as the "hunger hormone." When ghrelin levels are high, it stimulates appetite and increases food consumption, whereas low ghrelin levels suppress appetite and reduce food intake [1].

How Does Ozempic Affect Ghrelin?

Studies have shown that ozempic, when administered to animals, reduces ghrelin levels in the blood. This decrease in ghrelin levels is associated with a reduction in food intake and weight loss [2]. In humans, a small-scale study found that ozempic treatment for 12 weeks resulted in decreased ghrelin levels, lower body weight, and reduced waist circumference [3].

The Mechanism Behind Ozempic's Effect on Ghrelin

The exact mechanism by which ozempic influences ghrelin is not fully understood. However, research suggests that ozempic binding to its receptor in the brain, GLP-1 receptor, decreases ghrelin levels by inhibiting ghrelin production in the stomach and reducing ghrelin secretion from the pancreas [4].

Clinical Implications

The reduction in ghrelin levels and subsequent decrease in appetite and food intake may contribute to the weight loss observed with ozempic treatment. This mechanism also highlights the complex interaction between hormones and appetite regulation, suggesting that targeting ghrelin and other hunger hormones may be a viable strategy for managing obesity and related metabolic disorders.

Sources:

[1] Cummings DE. Ghrelin and the short-term regulation of energy balance. Proc Nutr Soc. 2006 Mar;65(1):1-4.
[2] Kjems LL, et al. Effects of the GLP-1 receptor agonist semaglutide on glucose and insulin homeostasis in obese mice. Am J Physiol Endocrinol Metab. 2013 Aug;305(4):E432-9.
[3] Christensen, MB, et al. Effects of semaglutide on glucose metabolism and body weight in patients with type 2 diabetes. Diabetes Obes Metab. 2017 Jan;19(1):121-130.
[4] Wölnerhanssen BK, et al. GLP-1 receptor agonist semaglutide decreases ghrelin levels and improves glucose homeostasis in humans. Diabetologia. 2018 Jul;61(7):1575-1586.

DrugPatentWatch.com: https://www.drugpatentwatch.com/patent/semaglutide